Migraine Cut herbal nasal spray and headache

The effect of Migraine Cut herbal nasal spray on headache severity and quality of life in patients with migraine

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210503051168N1

Enrollment

Registered

2021-06-09

Start date

2021-07-10

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group: Patients in this group are routinely treated for migraine prophylaxis, including Depakine 250 mg 1 time per night, and also given a migraine cut nasal spray every 6

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed case of migraine Not using migraine medications Age 18 to 60 years Have a minimum literacy rate Satisfaction with participation in this study

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Suffering from any chronic physical and mental illness Previous use of migraine prophylaxis Contraindications to anticonvulsant drugs Consumers of anticoagulants Epilepsy Chronic diseases of the gastrointestinal tract

Design outcomes

Primary

Measure	Time frame
Severity of headache. Timepoint: At the beginning of the intervention and after three months. Method of measurement: Visual Analogue Scale questionnaire.;Quality of Life. Timepoint: At the beginning of the intervention and after three months. Method of measurement: Migraine Disability Assessment scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHeliya Hemasian

Esfahan University of Medical Sciences

h.hemasian@med.mui.ac.ir+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026